Huawei and Imperial College London sign MoU to Explore Research Collaboration
News Jul 02, 2013
Imperial and Huawei plan to collaborate on a joint R&D hub, enabling academic researchers and business experts to collectively develop innovations and applications in research areas including digital, energy, healthcare, future cities and life sciences. The centre will focus on the emergent field of data science as Imperial and Huawei work to harness the latest scientific and technological breakthroughs around big data and translate them into real world applications. The proposed joint centre would be located on Imperial's new research and translation campus, Imperial West, in White City, West London.
The MoU was signed by Sir Keith O'Nions, President & Rector of Imperial College London, and William Xu, Chief Executive of Huawei's Enterprise Business Group. Oliver Letwin MP, Minister of State at the Cabinet Office, attended the signing ceremony at Imperial and underlined the Government's support for the partnership.
Under the terms of the MoU, Imperial and Huawei have also agreed to spend a year exploring other opportunities for collaboration over the next decade; a joint working party will be established to determine the next stages of the partnership. Options being considered include a 'Huawei-Imperial Joint Innovation Centre' suite, which would be used by Imperial researchers, students and Huawei staff as a meeting and workspace. The suite could also act as a state-of-the-art demonstration centre where technology, including Huawei solutions, can be viewed by the public.
David Willetts MP, Universities and Science Minister, said:
"Huawei's decision to collaborate with Imperial College London will keep the UK as a global leader in big data. As one of the eight great technologies of the future, big data will allow scientists to research and analyse large information sets to support new innovations across industries such as space, bioscience and healthcare. This initiative is good news for the UK's science base, universities and the economy."
Sir Keith O'Nions, President & Rector of Imperial College London, said:
"We are excited to have taken the first step in what we hope will be a long-term collaboration with Huawei, a company which plays a major role in the global ICT industry. Imperial and Huawei share a commitment to translating research, innovation and developing next generation data science technology for the benefit of society and the economy. This parallels Imperial College's broader vision for Imperial West."
William Xu, Chief Executive, Enterprise Business Group, Huawei, said:
"Imperial is one of the world's great universities and I am delighted to begin this relationship. We intend for this Memorandum of Understanding to lead to a significant partnership in London and to reinforce our commitment to the UK. R&D has always been a top priority for Huawei and this continues to be the case as we expand our UK operations. Imperial College is a leader in global academic research, and the skills and expertise of the university will be invaluable in the development and success of Huawei Innovation Europe. I am very excited by the potential of this partnership and look forward to working with the university over the next 12 months and beyond."
Watch: Could Digital Microfluidics Revolutionise Experimentation?News
Technology using 'programmable droplets' could enable automated research on a grand scale.READ MORE
New Research Could Significantly Accelerate Drug DiscoveryNews
Scientists have developed a suite of computer programs that cull through data on structure and genomic sequencing to identify the features that distinguish one enzyme from similar enzymes. This research has the potential to significantly accelerate drug discovery, allowing scientists to develop more effective drugs, more quickly.READ MORE
Toothpaste Ingredient Could Help Fight Drug-Resistant MalariaNews
An ingredient commonly found in toothpaste could be employed as an anti-malarial drug against strains of malaria parasite that have grown resistant to one of the currently-used drugs.READ MORE